Literature DB >> 24135282

DNp73 exerts function in metastasis initiation by disconnecting the inhibitory role of EPLIN on IGF1R-AKT/STAT3 signaling.

Marc Steder1, Vijay Alla, Claudia Meier, Alf Spitschak, Jens Pahnke, Katharina Fürst, Bhavani S Kowtharapu, David Engelmann, Janine Petigk, Friederike Egberts, Susanne G Schäd-Trcka, Gerd Gross, Dirk M Nettelbeck, Annett Niemetz, Brigitte M Pützer.   

Abstract

Dissemination of cancer cells from primary tumors is the key event in metastasis, but specific determinants are widely unknown. Here, we show that DNp73, an inhibitor of the p53 tumor suppressor family, drives migration and invasion of nonmetastatic melanoma cells. Knockdown of endogenous DNp73 reduces this behavior in highly metastatic cell lines. Tumor xenografts expressing DNp73 show a higher ability to invade and metastasize, while growth remains unaffected. DNp73 facilitates an EMT-like phenotype with loss of E-cadherin and Slug upregulation. We provide mechanistic insight toward regulation of LIMA1/EPLIN by p73/DNp73 and demonstrate a direct link between the DNp73-EPLIN axis and IGF1R-AKT/STAT3 activation. These findings establish initiation of the invasion-metastasis cascade via EPLIN-dependent IGF1R regulation as major activity of DNp73.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24135282     DOI: 10.1016/j.ccr.2013.08.023

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  36 in total

1.  Tyr99 phosphorylation determines the regulatory milieu of tumor suppressor p73.

Authors:  Y K Satija; S Das
Journal:  Oncogene       Date:  2015-04-20       Impact factor: 9.867

Review 2.  Clinical implications of the deregulated TP73 isoforms expression in cancer.

Authors:  N Rodríguez; A Peláez; R Barderas; G Domínguez
Journal:  Clin Transl Oncol       Date:  2017-12-11       Impact factor: 3.405

Review 3.  A balancing act: orchestrating amino-truncated and full-length p73 variants as decisive factors in cancer progression.

Authors:  D Engelmann; C Meier; V Alla; B M Pützer
Journal:  Oncogene       Date:  2014-11-10       Impact factor: 9.867

4.  TAp73 suppresses tumor angiogenesis through repression of proangiogenic cytokines and HIF-1α activity.

Authors:  Marina Stantic; Habib A M Sakil; Hanna Zirath; Trixy Fang; Gema Sanz; Alejandro Fernandez-Woodbridge; Ana Marin; Evelyn Susanto; Tak W Mak; Marie Arsenian Henriksson; Margareta T Wilhelm
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-22       Impact factor: 11.205

5.  Human phosphatase CDC14A regulates actin organization through dephosphorylation of epithelial protein lost in neoplasm.

Authors:  Nan-Peng Chen; Borhan Uddin; Robert Hardt; Wen Ding; Marko Panic; Ilaria Lucibello; Patricia Kammerer; Thomas Ruppert; Elmar Schiebel
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-02       Impact factor: 11.205

6.  p73 is required for endothelial cell differentiation, migration and the formation of vascular networks regulating VEGF and TGFβ signaling.

Authors:  R Fernandez-Alonso; M Martin-Lopez; L Gonzalez-Cano; S Garcia; F Castrillo; I Diez-Prieto; A Fernandez-Corona; M E Lorenzo-Marcos; X Li; L Claesson-Welsh; M M Marques; M C Marin
Journal:  Cell Death Differ       Date:  2015-01-09       Impact factor: 15.828

Review 7.  p73 isoforms meet evolution of metastasis.

Authors:  Stella Logotheti; Athanasia Pavlopoulou; Stephan Marquardt; Işıl Takan; Alexandros G Georgakilas; Thorsten Stiewe
Journal:  Cancer Metastasis Rev       Date:  2022-08-11       Impact factor: 9.237

8.  p53 Activity Dominates That of p73 upon Mdm4 Loss in Development and Tumorigenesis.

Authors:  Mehrnoosh Tashakori; Yun Zhang; Shunbin Xiong; M James You; Guillermina Lozano
Journal:  Mol Cancer Res       Date:  2015-11-02       Impact factor: 5.852

9.  SATB2 enhances migration and invasion in osteosarcoma by regulating genes involved in cytoskeletal organization.

Authors:  B K A Seong; J Lau; T Adderley; L Kee; D Chaukos; M Pienkowska; D Malkin; P Thorner; M S Irwin
Journal:  Oncogene       Date:  2014-09-15       Impact factor: 9.867

10.  CRNDE Promotes Malignant Progression of Glioma by Attenuating miR-384/PIWIL4/STAT3 Axis.

Authors:  Jian Zheng; Xiaobai Liu; Ping Wang; Yixue Xue; Jun Ma; Chengbin Qu; Yunhui Liu
Journal:  Mol Ther       Date:  2016-04-08       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.